Overview

Evaluation of Effect of Integrated Treatment by Traditional Chinese and Western Medicine for Severe Acute Pancreatitis

Status:
Unknown status
Trial end date:
2009-10-01
Target enrollment:
0
Participant gender:
All
Summary
With multicenter randomized control clinical evaluation investigations, the scheme of integrated medicine treatment of severe acute pancreatitis (SAP) was further improved, and the therapeutic effects, safety and indications assured. Drawing in latest research fruits at home and abroad, a clinical practical guideline for integrated medicine of diagnosis and treatment of SAP would be formed, to be popularized all over China.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Tianjin Nankai Hospital
Collaborator:
Sichuan University
Criteria
Inclusion Criteria:

- Adult patients 18yr-70yr, complying with the diagnostic standard of acute pancretitis
(clinical symptoms and signs, elevated blood and urine amylase, and imaging criteria),
conforming to 3 or more Ranson's criteria and APACHE-II score larger than 8, Balhazar
CT score larger than 5.

Exclusion Criteria:

- Pregnancy, nursing mother, critical cases of advanced tumor, on the verge of death
(estimated to be moral in 12h), severe visceral function disturbance, patients
undergoing other therapeutic research that might interfere with the present study.